PEPGPepGen Inc.

$435M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$23M

Net Income

-$21M

EPS (Diluted)

$-0.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$170M

Total Liabilities

$33M

Stockholders' Equity

$137M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$23M	-$25M	+6.5%
Net Income	-$21M	-$23M	+8.2%

PEPG Q3 2024 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena